Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.58 USD | -0.03% |
|
+9.08% | +50.85% |
12:00am | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 1000 | CI |
12:00am | Protagonist Therapeutics, Inc.(NasdaqGM:PTGX) added to S&P 600 Health Care | CI |
Evolution of the average Target Price on Protagonist Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Protagonist Therapeutics, Inc.
JPMorgan Chase | |
Capital One Securities | |
JMP Securities | |
HC Wainwright | |
Piper Sandler | |
SVB Leerink | |
BTIG | |
Northland Securities |
EPS Revisions
- Stock Market
- Equities
- PTGX Stock
- Consensus Protagonist Therapeutics, Inc.